Histone deacetylase inhibition modulates kynurenine pathway activation in yeast, microglia, and mice expressing a mutant huntingtin fragment
- PMID: 18079112
- DOI: 10.1074/jbc.M708192200
Histone deacetylase inhibition modulates kynurenine pathway activation in yeast, microglia, and mice expressing a mutant huntingtin fragment
Abstract
The kynurenine pathway of tryptophan degradation is hypothesized to play an important role in Huntington disease, a neurodegenerative disorder caused by a polyglutamine expansion in the protein huntingtin. Neurotoxic metabolites of the kynurenine pathway, generated in microglia and macrophages, are present at increased levels in the brains of patients and mouse models during early stages of disease, but the mechanism by which kynurenine pathway up-regulation occurs in Huntington disease is unknown. Here we report that expression of a mutant huntingtin fragment was sufficient to induce transcription of the kynurenine pathway in yeast and that this induction was abrogated by impairing the activity of the histone deacetylase Rpd3. Moreover, numerous genetic suppressors of mutant huntingtin toxicity that are functionally unrelated converged unexpectedly on the kynurenine pathway, supporting a critical role for the kynurenine pathway in mediating mutant huntingtin toxicity in yeast. Histone deacetylase-dependent regulation of the kynurenine pathway was also observed in a mouse model of Huntington disease, in which treatment with a neuroprotective histone deacetylase inhibitor blocked activation of the kynurenine pathway in microglia expressing a mutant huntingtin fragment in vitro and in vivo. These findings suggest that a mutant huntingtin fragment can perturb transcriptional programs in microglia, and thus implicate these cells as potential modulators of neurodegeneration in Huntington disease that are worthy of further investigation.
Similar articles
-
A genomic screen in yeast implicates kynurenine 3-monooxygenase as a therapeutic target for Huntington disease.Nat Genet. 2005 May;37(5):526-31. doi: 10.1038/ng1542. Epub 2005 Apr 3. Nat Genet. 2005. PMID: 15806102 Free PMC article.
-
Mutant Huntingtin promotes autonomous microglia activation via myeloid lineage-determining factors.Nat Neurosci. 2014 Apr;17(4):513-21. doi: 10.1038/nn.3668. Epub 2014 Mar 2. Nat Neurosci. 2014. PMID: 24584051 Free PMC article.
-
Early kynurenergic impairment in Huntington's disease and in a transgenic animal model.Neurosci Lett. 2000 Apr 14;283(3):233-5. doi: 10.1016/s0304-3940(00)00956-3. Neurosci Lett. 2000. PMID: 10754231
-
Histone deacetylase inhibitors: a novel therapeutic approach to Huntington's disease (complex mechanism of neuronal death).Curr Alzheimer Res. 2006 Sep;3(4):403-8. doi: 10.2174/156720506778249407. Curr Alzheimer Res. 2006. PMID: 17017871 Review.
-
Huntington disease: new insights on the role of huntingtin cleavage.J Neural Transm Suppl. 2000;(58):1-17. doi: 10.1007/978-3-7091-6284-2_1. J Neural Transm Suppl. 2000. PMID: 11128600 Review.
Cited by
-
Polyglutamine (polyQ) disorders: the chromatin connection.Nucleus. 2012 Sep-Oct;3(5):433-41. doi: 10.4161/nucl.21481. Epub 2012 Aug 15. Nucleus. 2012. PMID: 22892726 Free PMC article. Review.
-
Structural basis of kynurenine 3-monooxygenase inhibition.Nature. 2013 Apr 18;496(7445):382-5. doi: 10.1038/nature12039. Epub 2013 Apr 10. Nature. 2013. PMID: 23575632 Free PMC article.
-
A brain-permeable inhibitor of the neurodegenerative disease target kynurenine 3-monooxygenase prevents accumulation of neurotoxic metabolites.Commun Biol. 2019 Jul 24;2:271. doi: 10.1038/s42003-019-0520-5. eCollection 2019. Commun Biol. 2019. PMID: 31372510 Free PMC article.
-
Targeted deletion of kynurenine 3-monooxygenase in mice: a new tool for studying kynurenine pathway metabolism in periphery and brain.J Biol Chem. 2013 Dec 20;288(51):36554-66. doi: 10.1074/jbc.M113.503813. Epub 2013 Nov 4. J Biol Chem. 2013. PMID: 24189070 Free PMC article.
-
Contribution of yeast models to neurodegeneration research.J Biomed Biotechnol. 2012;2012:941232. doi: 10.1155/2012/941232. Epub 2012 Jul 15. J Biomed Biotechnol. 2012. PMID: 22910375 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases